Financials

  • Market Capitalization 517.63 M
  • Employee 149
  • Founded 2018
  • CEO N/A
  • Website www.kyvernatx.com
  • Headquarter Delaware, United States
  • FIGI BBG00RCYMHR1
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
2885
OVID
Ovid Therapeutics Inc. - Common Stock
2.69 USD-3.93%-2.54%+21.17%+115.20%525.35 M USD
2892
ENTX
Entera Bio Ltd. - Ordinary Shares
3.00 USD-0.99%-12.02%+3.09%+54.64%519.43 M USD
2940
EVMN
Evommune, Inc. Common Stock
13.22 USD-1.56%-3.43%+18.67%-23.67%479.78 M USD
2948
PRTA
Prothena Corporation plc - Ordinary Shares
9.23 USD-1.07%-1.07%+12.97%+12.97%473.84 M USD